Press Releases
April 24, 2025
Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research
April 22, 2025
Debiopharm to Reveal Insights from their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at The 2025 AACR Conference in…
March 12, 2025
Debiopharm mutualise son infrastructure de bornes de recharges pour les taxis électriques ou hybrides de Lausanne
February 25, 2025
MEDSIR & Debiopharm Announce the First Patient Dosed in the WIN-B Trial Exploring the Combination of Debio 0123 & Gilead’s…
January 29, 2025
Genialis advances biomarker discovery to reduce risk in cancer drug development targeting DNA damage response pathways
January 14, 2025
Swiss-based non-profit GARDP supports the development of Debiopharm’s new potential treatment for gonorrhoea